Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Am Coll Clin Pharm. 2018 Nov 22;2(3):214–221. doi: 10.1002/jac5.1062

Table 1.

Summary of Survey Participants (N=135) and Responses

Physician Respondents (n=76) (%) Pharmacist Respondents (n=59) (%)
Number of years in practice
Less than 5 years 11 (14) 20 (34)
5–10 years 16 (21) 20 (34)
More than 10 years 49 (64) 19 (32)
Survey response rate 27% 50%
Medical specialty (response rate)
  Cardiology 9 (20) 9
  Infectious diseases 5 (ND) 12
  Neurology 4 (ND) 7
  Oncology 9 (47) 7
  Pain 11 (48) 9
  Primary care 16 (27) 18
  Psychiatry 14 (ND) 5
  Transplant 11 (35) 17
Currently using PG testing in practice 22 (29) 19 (32)
Interest in starting PG testing in practice 48 (63) 32 (54)
Currently not using PG and not interested in integrating PG 6 (8) 8 (14)
Clinicians indicating interest in discussing their interest in clinical PG with us 49 (64) 33 (56)
Observational studies sufficient evidence for PG testing 45 (59) 35 (59)

ND = not determined; PG = pharmacogenetics.

Response rate for pharmacists across medical specialties is not determined given that all pharmacists selected more than one clinical specialty in the survey.

Unable to calculate response rate because we did not know the number of physicians who received the survey.